Lumexa Imaging (LMRI) CFO reports dual 388,888-share option grants holdings

Rhea-AI Filing Summary

Lumexa Imaging Holdings, Inc. reported initial equity holdings for Chief Financial Officer Martin James Anthony. He beneficially holds two stock option awards, each covering 388,888 shares of common stock at an exercise price of $18.50 per share. One option vests in five substantially equal annual installments starting from January 1, 2025, conditioned on his continued service. The second option vests in three installments tied to stock price targets of $27.00, $36.00, and $45.00 per share, measured over any 60‑trading‑day volume weighted average price after a 180‑day lock‑up period, also requiring continued service. The filing notes it was submitted late due to delays obtaining EDGAR codes.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Martin James Anthony

(Last) (First) (Middle)

4200 SIX FORKS ROAD

SUITE 1000

(Street)

RALEIGH NC 27609

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
12/11/2025

3. Issuer Name and Ticker or Trading Symbol
Lumexa Imaging Holdings, Inc. [ LMRI ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	(1)	12/10/2035	Common Stock	388,888	$18.5	D
Stock Option (right to buy)	(2)	12/10/2035	Common Stock	388,888	$18.5	D

Explanation of Responses:

1. The shares of the Issuer's common stock ("Common Stock") subject to the stock option vest annually in five substantially equal installments from the vesting commencement date of January 1, 2025, subject to the Reporting Person's continued service with the Issuer.

2. The shares of Common Stock subject to the stock option will vest in three substantially equal installments upon the attainment of three prescribed stock price targets of $27.00, $36.00 and $45.00 per share, which targets are measured based on the volume weighted average closing price per share of Common Stock over any consecutive sixty (60) trading day period, with the measurement period commencing on the first business day immediately following the expiration of the 180-day lock-up period, subject to the Reporting Person's continued service with the Issuer.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney. This Form 3 is being filed late due to unanticipated delays in receiving the Reporting Person's EDGAR codes, which delays we understand were due to the high volume of applications at the time.

	/s/ Julie Szeker, attorney-in-fact	01/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does Lumexa Imaging Holdings (LMRI) disclose in this Form 3?

The filing discloses Chief Financial Officer Martin James Anthony’s beneficial ownership of two stock option awards on Lumexa Imaging Holdings, Inc. common stock.

How many Lumexa Imaging (LMRI) shares are covered by the CFO’s options?

Each stock option held by the CFO covers 388,888 shares of Lumexa Imaging common stock, for a total of two separate option awards.

What is the exercise price of the CFO’s Lumexa Imaging stock options?

Both stock option awards reported have an exercise price of $18.50 per share of Lumexa Imaging common stock.

How do the time-based Lumexa Imaging (LMRI) CFO options vest?

One option award vests in five substantially equal annual installments starting from the vesting commencement date of January 1, 2025, subject to the CFO’s continued service.

What stock price targets affect the CFO’s performance-based options at Lumexa Imaging?

The performance-based option vests in three equal installments upon achieving volume weighted average price targets of $27.00, $36.00 and $45.00 per share over any 60 trading days after a 180-day lock-up period.

Why was this Lumexa Imaging (LMRI) Form 3 filed late?

The document states it was filed late due to unanticipated delays in receiving the reporting person’s EDGAR codes, which were affected by a high volume of applications.

What is the reporting person’s role at Lumexa Imaging Holdings (LMRI)?

The reporting person, Martin James Anthony, is identified as an officer of Lumexa Imaging Holdings, Inc., serving as Chief Financial Officer.